carotid artery stenting versus medical treatment | |||
SAMMPRIS, 2011 NCT00576693 | aggressive medical management plus percutaneous transluminal angioplasty and stenting versus aggressive medical management alone | patients who had a recent transient ischemic attack or stroke attributed to stenosis of 70 to 99% of the diameter of a major intracranial artery | open Follow-up duration: 11.9 months |
carotid artery stenting versus surgery | |||
Leicester (Naylor), 1998 | Self-expanding Wallstent versus surgery | patients with focal carotid territory symptoms and severe ICA stenosis (> 70%) | open Follow-up duration: 1 month |
WALLSTENT (Alberts), 2001 | Wallstent versus | open Follow-up duration: 12 months | |
CAVATAS-CEA, 2001 ISRCTN01425573 | Pre-1994: PTA only after 1994: Wallstent, Streker, Palmaz versus carotid endarterectomy | patients of any age with symptomatic or asymptomatic carotid artery stenosis suitable for surgery | open Follow-up duration: 36 months (4y) |
Kentucky A (Brooks), 2001 | Wallstent versus surgery | patients presenting with cerebrovascular ischemia ipsilateral to carotid stenosis | open Follow-up duration: 48 months |
Kentucky B (Brooks), 2004 | Wallstent, Dynalink versus carotid endarterectomy | patients with asymptomatic carotid stenosis of more than 80% were selected | open Follow-up duration: 48 months |
SAPPHIRE (yadav), 2004 | Smart or Precise (self-expanding nitinol stent)age/pj versus surgery | patients with coexisting conditions that potentially increased the risk posed by endarterectomy and who had either a symptomatic carotid-artery stenosis of at least 50 percent of the luminal diameter or an asymptomatic stenosis of at least 80 percent | open Follow-up duration: 36 months |
EVA-3S (Mas), 2000 | various stent versus endarterectomy | patients with a symptomatic carotid stenosis of at least 60% | open Follow-up duration: 6 months |
SPACE, 2000 | carotid-artery stenting (Carotid Wallstent; Precise; Acculink) versus Carotid endarterectomy | patients with symptomatic carotid-artery stenosis within 180 days of transient ischaemic attack or moderate stroke (modified Rankin scale score of < or =3) | open Follow-up duration: 1 month |
TESCAS-C (Ling), 2006 | versus | open Follow-up duration: 6 months | |
BACASS (Hoffman), 2006 | stent versus CEA | patients with symptomatic carotid stenosis > 70% | open Follow-up duration: 45 months |
Steinbauer, 2008 | carotid artery stenting versus Carotid endarterectomy | Follow-up duration: 65 months | |
ICSS, 2010 ISRCTN25337470 | carotid artery stenting versus endarterectomy | patients with symptomatic carotid stenosis of greater than 50% within last six months | open Follow-up duration: 120 days Europe, Autralia, New Zealand, Canada |
CREST, 2010 NCT00004732 | carotid artery stenting (with distal-protection) versus carotid endarterectomy | patients with both asymptomatic and symptomatic extracranial carotid stenosis | open Follow-up duration: 2.5y US, Canada |
carotid endarterectomy versus control | |||
ACST, 1994 | CEA as soon as possible, standard medical treatment including antiplatelet drugs versus no CEA unless symptoms occurred, standard medical treatment including antiplatelet drugs | Asymptomatic carotid artery stenosis of 60% or greater | open Follow-up duration: 3.4y mean Europe |
VA, 1993 | carotid endarterectomy aspirin 650 mg bd versus aspirin 650 mg bd | Asymptomatic carotid artery stenosis of 50-99% | open Follow-up duration: 4 y (mean) US |
ACAS, 1995 | carotid endarterectomy, aspirin 325 mg daily versus aspirin 325 mg daily | Asymptomatic carotid artery stenosis of 60% or greater | open Follow-up duration: 2.7 y mean North America |
ECST, 1998 | surgery versus control | men and women of any age, with some degree of carotid stenosis, who within the previous 6 months had had at least one transient or mild symptomatic ischaemic vascular event in the distribution of one or both carotid arteries | open Follow-up duration: 6.1 years |
NASCET, 1998 | carotid endarterectomy versus medical care alone | Patients with moderate (<70%) carotid stenosis and transient ischemic attacks or nondisabling strokes on the same side as the stenosis (ipsilateral) within 180 days | open Follow-up duration: 5 years |
VA309, 1991 | Carotid endarterectomy plus the best medical care versus best medical care alone | Men who presented within 120 days of onset of symptoms that were consistent with transient ischemic attacks, transient monocular blindness, or recent small completed strokes and with with angiographic internal carotid artery stenosis greater than 50% ipsilateral to the presenting symptoms | open Follow-up duration: 11.9 months |